
An update on Cutneedle® presented at 2019’s VEITHsimposium
Vincent Riambau has presented an update on our Cutneedle® at this year’s VEITHsimposium.
Vincent Riambau has presented an update on our Cutneedle® at this year’s VEITHsimposium.
Both of VB Device’s developments have been selected for presentation at the 40th Charing Cross Meeting next April. CX is probably the most prestigious vascular meeting in Europe and the oldest specialty meeting.
This project has received funding from the European Union's Horizon 2020 research and innovation programme under grant agreement No 887677
Necessary cookies only include cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function.
Analytical cookiesFederico Grego has more than 20 years of experience in the pharmaceutical industry (LETI Pharma), in senior management positions, coupled with 4 years of experience in investment banking (HSBC). He also has extensive experience in the biomedical entrepreneurship sector helping to promote various projects, including Cytovation AS, Allero Therapeutics, and Nexkin Medical, among others. He is an economist (Tufts University), MBA (IESE) and AMP Certificate (Harvard).